Literature DB >> 30736111

Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment.

Maria Vittoria Davì1, Andrea Giustina2.   

Abstract

Sleep apnea syndrome is a common complication of acromegaly with a negative impact on quality of life and survival. Obstructive sleep apnea is the prevailing form and is characterized by recurrent episodes of apnea and hypopnea owing to the total or partial collapse of the upper airways during sleep. The craniofacial deformations and the hypertrophy of upper airway soft tissue are responsible for its occurrence. Successful treatment of acromegaly can improve the severity of this complication, but can only seldom reverse it, particularly after a long time of active acromegaly. Thus, it is advisable to evaluate patients for sleep apnea syndrome at diagnosis and during treatment, and also when acromegaly is biochemically controlled. In selected cases, continuous positive airway pressure should be implemented to improve patient outcome.

Entities:  

Keywords:  GH; IGF-1; acromegaly; diabetes mellitus; pegvisomant; sleep apnea; somatostatin analogs

Year:  2012        PMID: 30736111     DOI: 10.1586/eem.11.82

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  5 in total

1.  Densely granulated adenoma pattern is associated with an increased risk of obstructive sleep apnea in patients with acromegaly.

Authors:  Xianchao Zhao; Lijun Heng; Yan Qu; Dong Jia; Jiafeng Ren; Shuyu Sun; Jian Qiu; Jinxiang Cheng; Ting Yang; Junying Zhou; Changjun Su
Journal:  Sleep Breath       Date:  2021-08-12       Impact factor: 2.655

Review 2.  Acromegaly in the elderly patients.

Authors:  Maria Rosaria Ambrosio; Irene Gagliardi; Sabrina Chiloiro; Ana Gonçalves Ferreira; Marta Bondanelli; Antonella Giampietro; Antonio Bianchi; Laura De Marinis; Maria Fleseriu; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2020-02-14       Impact factor: 3.633

3.  Evaluation of Acromegaly patients with sleep disturbance related symptoms.

Authors:  Deniz Celik; Sezgi Sahin Duyar; Funda Aksu; Selma Firat; Bulent Ciftci
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 2.340

Review 4.  Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide.

Authors:  Soraya Puglisi; Francesco Ferraù; Marta Ragonese; Federica Spagnolo; Salvatore Cannavò
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-06       Impact factor: 5.555

5.  Cost-Utility of Acromegaly Pharmacological Treatments in a French Context.

Authors:  Thierry Brue; Philippe Chanson; Patrice Rodien; Brigitte Delemer; Delphine Drui; Lucile Marié; Laurène Juban; Lara Salvi; Robin Henocque; Gérald Raverot
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-07       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.